FDA Inspection 1221431 — Wavepoint-R1W
The FDA completed an inspection of Wavepoint-R1W on August 14, 2023 in North East, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 14, 2023
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- North East, PA (United States)